Use of C-type natriuretic peptide variants to treat skeletal dysplasia
US-12514906-B2 · Jan 6, 2026 · US
Biomarin Pharm Inc holds 222 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 222 |
| Recent patents | 40 |
| First publication | Jan 27, 2015 |
| Latest publication | Jan 6, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12514906-B2 · Jan 6, 2026 · US
US-2025388644-A1 · Dec 25, 2025 · US
US-2025332224-A1 · Oct 30, 2025 · US
US-2025170217-A1 · May 29, 2025 · US
US-2025161466-A1 · May 22, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12514906-B2 · Jan 6, 2026 · US
US-2025388644-A1 · Dec 25, 2025 · US
US-2025332224-A1 · Oct 30, 2025 · US
US-2025170217-A1 · May 29, 2025 · US
US-2025161466-A1 · May 22, 2025 · US
Most common classification codes in this portfolio.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 196 |
| Human Necessities | 190 |
| Physics | 47 |
| Cross-Sectional Technologies | 10 |
| Operations & Transport | 2 |
| Mechanical Engineering | 1 |
| Electricity | 1 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.